These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3516486)

  • 1. Clinical studies of ABMT in non-Hodgkin's lymphoma.
    Singer CR; Goldstone AH
    Clin Haematol; 1986 Feb; 15(1):105-50. PubMed ID: 3516486
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of the clinical relevance of autologous bone marrow transplantation.
    Appelbaum FR; Buckner CD
    Clin Haematol; 1986 Feb; 15(1):1-18. PubMed ID: 3516484
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
    Phillips GL; Reece DE
    Clin Haematol; 1986 Feb; 15(1):151-66. PubMed ID: 3516487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation.
    Sullivan KM; Appelbaum FR; Horning SJ; Rosenberg SA; Thomas ED
    Int J Cell Cloning; 1986; 4 Suppl 1():94-106. PubMed ID: 3528333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin's lymphoma.
    Philip T; Biron P; Maraninchi D; Goldstone AH; Herve P; Souillet G; Gastaut JL; Plouvier E; Flesh Y; Philip I
    Br J Haematol; 1985 Aug; 60(4):599-609. PubMed ID: 3896295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis.
    Philip T; Biron P; Hervé P; Dutou L; Ehrsam A; Philip I; Souillet G; Plouvier E; Le Mevel A; Philippe N
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1371-9. PubMed ID: 6357803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma.
    Lazarus HM; Crilley P; Ciobanu N; Creger RJ; Fox RM; Shina DC; Bulova SI; Gucalp R; Cooper BW; Topolsky D
    J Clin Oncol; 1992 Nov; 10(11):1682-9. PubMed ID: 1403051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas.
    Gorin NC; Najman A; Douay L; Salmon C; David R; Stachowiak J; Parlier Y; Lopez M; Oppenheimer M; Lecomte D
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):217-25. PubMed ID: 6368242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.
    Weaver CH; Appelbaum FR; Petersen FB; Clift R; Singer J; Press O; Bensinger W; Bianco J; Martin P; Anasetti C
    J Clin Oncol; 1993 Jul; 11(7):1329-35. PubMed ID: 8315430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
    Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
    J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation in the treatment of malignant lymphoma and Hodgkin's disease.
    Canellos GP; Nadler L; Takvorian T
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):58-65. PubMed ID: 3041601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT.
    Liberti G; Pearce R; Taghipour G; Majolino I; Goldstone AH
    Ann Oncol; 1994; 5 Suppl 2():151-3. PubMed ID: 7911318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-Hodgkin's malignant lymphoma. Therapeutic value of autologous bone marrow transplantation].
    Gorin NC; Najman A; Douay L; Salmon C; David R; Stachowiak J; Parlier Y; Oppenheimer M; Lecomte D; Lopez M
    Presse Med; 1983 Sep; 12(31):1917-23. PubMed ID: 6226002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma.
    Philip T; Pinkerton R; Hartmann O; Patte C; Philip I; Biron P; Favrot M
    Clin Haematol; 1986 Feb; 15(1):205-17. PubMed ID: 3516490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
    Stahel RA; Jost LM; Cerny T; Pichert G; Honegger H; Tobler A; Jacky E; Fey M; Platzer E
    J Clin Oncol; 1994 Sep; 12(9):1931-8. PubMed ID: 7521907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas.
    Gribben JG; Vaughan Hudson B; Linch DC
    Hematol Oncol; 1987; 5(4):281-93. PubMed ID: 3319868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of syngeneic marrow transplantation and its relevance to autografting.
    Fefer A
    Clin Haematol; 1986 Feb; 15(1):49-65. PubMed ID: 3516493
    [No Abstract]   [Full Text] [Related]  

  • 18. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.
    Younes A; Santoro A; Shipp M; Zinzani PL; Timmerman JM; Ansell S; Armand P; Fanale M; Ratanatharathorn V; Kuruvilla J; Cohen JB; Collins G; Savage KJ; Trneny M; Kato K; Farsaci B; Parker SM; Rodig S; Roemer MG; Ligon AH; Engert A
    Lancet Oncol; 2016 Sep; 17(9):1283-94. PubMed ID: 27451390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation in paediatric solid tumours.
    Pinkerton R; Philip T; Bouffet E; Lashford L; Kemshead J
    Clin Haematol; 1986 Feb; 15(1):187-203. PubMed ID: 3516489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.
    Brice P; Gisselbrecht C; Ferme C; Lepage E; Baruchel A; Marolleau JP; Gerota O; Boiron M
    Nouv Rev Fr Hematol (1978); 1991; 33(3):267-72. PubMed ID: 1956765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.